Last update:
Overweight & Obesity news
Overweight & Obesity
Why our waistlines expand in middle age—aging stem cells shift into overdrive
It's no secret that our waistlines often expand in middle age, but the problem isn't strictly cosmetic. Belly fat accelerates aging and slows down metabolism, increasing our risk for developing diabetes, heart problems and ...
Apr 25, 2025
0
373
Arthritis & Rheumatism
Repurposed diabetes drug can reduce pain for those with knee arthritis and overweight or obesity, clinical trial shows
A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee replacements, Monash University-led research has found.
Apr 25, 2025
0
80
Antibiotic exposure before age two linked to childhood obesity
Taking antibiotics within the first two years of life is linked to a higher body mass index (BMI) in childhood, according to a new study. The research was presented at the Pediatric Academic Societies (PAS) 2025 Meeting, ...
Apr 25, 2025
0
0
Investigating tirzepatide's role in weight loss and metabolic health
Researchers at the Pennington Biomedical Research Center conducted a first-of-its-kind study to provide insights into the mechanisms of action of tirzepatide—a drug known as Zepbound—on weight loss with respect to energy ...
Apr 24, 2025
0
1
Obesity triggers harmful signals that may worsen kidney disease, research finds
A comprehensive new review by researchers at the University of Kentucky sheds light on the intricate and damaging relationship between obesity and kidney disease.
Apr 24, 2025
0
0
Inhibition of an enzyme that promotes inflammation may reduce cardiovascular risk in obese people
A research team led by Dr. Martin Mollenhauer from the Heart Center at University Hospital Cologne has investigated the link between obesity and the risk of cardiovascular disease in greater detail. The researchers have discovered ...
Apr 23, 2025
0
33
How to maintain your weight after completing weight loss medications
Weight-loss medications help adjust the hormones that make a person feel hungry, causing them to feel full faster after eating small portions. However, once a person stops taking these medications, there is a likelihood of ...
Apr 23, 2025
1
1
Obesity disrupts molecular 'reaction time' to starvation in mice, study finds
Researchers led by Keigo Morita and Shinya Kuroda of the University of Tokyo have revealed a temporal disruption in the metabolism of obese mice when adapting to starvation despite no significant structural disruptions in ...
Apr 22, 2025
0
25
FDA and Novo Nordisk alert consumers to counterfeit Ozempic
The U.S. Food and Drug Administration and the pharmaceutical company Novo Nordisk are urging consumers to be on the lookout for counterfeit Ozempic (semaglutide) and to refrain from using the imitation drugs.
Apr 22, 2025
0
0
BMI remains a reliable indicator of excess body fat in most adults, study finds
Johns Hopkins University researchers have found that nearly all adults identified as having obesity based on body mass index (BMI) also had confirmed excess adiposity.
High-fat, high-sugar diets impact cognitive function
New research from the University of Sydney links fatty, sugary diets to impaired brain function. The findings build on a growing body of evidence showing the negative impact of high-fat, high-sugar (HFHS) diets on cognitive ...
Apr 21, 2025
0
45
New research reveals one in five boys and men may meet criteria for an eating disorder
A new study has found that over 1 in 5 boys and men in Canada and the United States may meet the diagnostic criteria for an eating disorder, highlighting the urgent need for greater awareness, tailored prevention efforts, ...
Apr 21, 2025
0
0
Research identifies new cut-off points for overweight and obesity in male athletes
New research presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that the internationally recognized body mass index (BMI) cut-off points greatly overestimate overweight and ...
Apr 18, 2025
0
2
First weight-loss pill from Lilly shows promising results
A new pill designed to help with weight loss and blood sugar control is showing promise in early studies.
Apr 18, 2025
0
0
Study finds women much more likely to be aware of and have good understanding of obesity drugs
New research being presented at this year's European Congress on Obesity (ECO 2025, Malaga, Spain, 11–14 May) shows that women are much more aware of and knowledgeable about the obesity drugs GLP-1/GIP receptor agonists ...
Apr 18, 2025
0
0
High school experiences linked to midlife body weight
High schools have long been recognized for shaping students' futures. According to a new study by researchers from Penn State, the University of Texas, the University of Wisconsin-Madison and the University of Minnesota, ...
Apr 17, 2025
0
41
School lunch program can reduce obesity among teenagers, especially those from lower socioeconomic backgrounds
A new study led by Professor Sayaka Nakamura from Sophia University in Japan and Professor Shiko Maruyama from Jinan University in China published in the journal Health Economics reveals the significant positive impact of ...
Apr 17, 2025
0
0
People are 'microdosing' weight-loss drugs—a GP explains what to watch out for
Injectable medications originally developed for the treatment of diabetes are also effective for weight loss and have surged in popularity for this purpose around the world.
Apr 17, 2025
0
1
Cold weather chills intentions to lose weight, study finds
While public health experts have raised concerns that warming global temperatures may be contributing to obesity, a new study by researchers at the University of Massachusetts Amherst and American University reveals a surprising ...
Apr 16, 2025
0
0
Study captures sharp uptake in use of new weight loss and glucose-lowering medications
When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in with the new.
Apr 15, 2025
0
0
Pfizer ends testing of obesity pill after possible liver injury
Pfizer has stopped developing a once-daily pill to treat obesity after a person in a clinical trial showed signs of a possible liver injury.
Apr 15, 2025
0
0
Adverse events from semaglutide seen in the ED usually gastrointestinal-related
The rate of emergency department visits for adverse events among patients dispensed semaglutide is low, with most visits involving gastrointestinal effects, according to a research letter published online April 8 in the Annals ...
Apr 15, 2025
0
0
Pregnancy complications contribute to cardiovascular risk for overweight women, study finds
Complications during pregnancy (or adverse pregnancy outcomes), like gestational diabetes and newly developed high blood pressure, act as nature's stress test and may uncover an individual's risk for heart disease later in ...
Apr 14, 2025
1
0
Tirzepatide produces clinically meaningful weight loss for at least 3 years in non-diabetic overweight adults: Trial
Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three years in adults with overweight or obesity who do not have diabetes, according to new research being presented ...
Apr 14, 2025
0
0
A patient-centered approach for managing obesity in children and adolescents
A new guideline to help health care providers manage obesity in children and adolescents takes a patient-centered approach, emphasizing behavioral and psychological supports that focus on outcomes valued by patients and their ...
Apr 14, 2025
1
0
